Gufic Biosciences Ltd - Stock Price

As on21 Oct 2021
  • NSE : GUFICBIO
  • BSE : 509079
  • ISIN CODE : INE742B01025
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Gufic Biosciences Ltd is not traded on BSE/NSE
NSE
185.45
+0.3 %+0.55
BSE
185.45
+0.22 %+0.4

Financials Quarterly Report

Parameter JUN 21  MAR 21  YoY %Change
Net Sales2507.581319.2990.07
Total Expenditure2051.101081.8289.60
PBIDT (Excl OI)456.48237.4792.23
Other Income12.286.5687.20
Operating Profit468.76244.0392.09
Interest12.0928.72-57.90
Exceptional ItemsNANANA
PBDT456.67215.31112.10
Depreciation41.2644.82-7.94
Profit Before Tax415.41170.49143.66
Tax103.3441.78147.34
Provisions and contingenciesNANANA
Profit After Tax312.07128.71142.46
Extraordinary ItemsNANANA
Prior Period ExpensesNANANA
Other Adjustments0.000.000.00
Net Profit312.07128.71142.46
Equity Capital96.9596.950.00
Face Value (IN RS)1.001.000.00
ReservesNANANA
Calculated EPS3.221.33142.46
Calculated EPS (Annualised)12.885.31142.46
No of Public Share Holdings33802198.0026653628.0026.82
% of Public Share Holdings34.8734.251.81
NANANANA
PBIDTM% (Excl OI)18.2018.001.13
PBIDTM%18.6918.501.06
PBDTM%18.2116.3211.59
PBTM%16.5712.9228.19
PATM%12.459.7627.56

About Gufic Biosciences Ltd.

Gufic Biosciences Ltd. was incorporated in the year 1984. Its today's share price is 185.45. Its current market capitalisation stands at Rs 1797.84 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4894.8 Cr and Total Income of Rs.4914.32 Cr. The company's management includes Ami Shah, Rabi N Sahoo, Balram Singh, Shrirang V Vaidya, Shreyas K Patel, Anu S Aurora, Gopal Daptari, Dilip B Ghosh, Pankaj J Gandhi, Pranav J Choksi, Jayesh P Choksi, Jayesh P Choksi.

It is listed on the BSE with a BSE Code of 509079 , NSE with an NSE Symbol of GUFICBIO and ISIN of INE742B01025. It's Registered office is at Shop - 37, First Floor,Kamala Bhavan I I,Swami Nityanand Road, Andheri EastMumbai-400069, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Mayur Chokshi & Co, Mittal Agarwal & Co, SHR & Co

Latest News

close